GlassScriptPhysician profile
Dan I Naim
NPI 1629272083
$13,622.58
in general payments reported to CMS, 2019-2025
53 companies · $2,473 in 2025
The $2,473 reported for 2025 was more than what 90% of Sleep Medicine (Internal Medicine) providers received nationally (typical 2025 total: $447).
See the full distribution for Sleep Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $659 · 2020: $597 · 2021: $1,849 · 2022: $2,140 · 2023: $2,934 · 2024: $2,970 · 2025: $2,473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,204 · Education: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,203.86 |
| Education | $173.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,894.17 | 2019-2025 | Breztri, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $1,645.68 | 2020-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Amgen INC. | $1,259.36 | 2020-2025 | Tezspire, Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,154.63 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Regeneron Healthcare Solutions, INC. | $482.18 | 2021-2024 | Dupixent |
| Baxter Healthcare | $451.70 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Cardiac Ambulatory Monitor |
| Jazz Pharmaceuticals INC. | $395.52 | 2023-2025 | |
| Electromed, INC. | $364.33 | 2021-2025 | Smartvest |
| Harmony Biosciences LLC | $342.96 | 2021-2025 | Wakix |
| Mylan Specialty L.P. | $318.53 | 2021-2024 | Yupelri |
| Insmed, INC. | $291.28 | 2024-2025 | Arikayce, Brinsupri |
| United Therapeutics Corporation | $283.62 | 2022-2025 | Tyvaso, Tyvaso |
| Mallinckrodt Hospital Products INC. | $264.84 | 2020-2024 | Acthar |
| Advanced Respiratory, INC | $262.63 | 2019-2021 | |
| Pfizer INC. | $239.44 | 2021-2025 |
Show all 53 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Naim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.